Charles Warlow, Joanna Wardlaw. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Brain Ischemia/drug therapyCerebral Hemorrhage/chemically inducedFibrinolytic Agents/therapeutic useHumansMyocardial Infarction/drug therapyRisk AssessmentThrombolytic Therapy/adverse effectsTissue Plasminogen Activator/therapeutic use
Substances: See more » Fibrinolytic AgentsTissue Plasminogen Activator
Year: 2003 PMID: 12560250 PMCID: PMC1125106 DOI: 10.1136/bmj.326.7383.233
Source DB: PubMed Journal: BMJ ISSN: 0959-8138